Mechanistic and Therapeutic Insights into Skeletal Biology Learned from the Study
从研究中获得的骨骼生物学机制和治疗见解
基本信息
- 批准号:8720467
- 负责人:
- 金额:$ 2.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-01 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAmericanApplications GrantsAreaBaltimoreBasic ScienceBiologicalBiologyBone DiseasesCellsClinicalClinical ResearchCollaborationsCongenital AbnormalityDevelopmentDiseaseDisease ProgressionEducational workshopEnsureEventFamilyFosteringFundingGenesGeneticGoalsGrowthHealthHealth AllianceHumanIndividualIndustryJointsJournalsKnowledgeLearningLive BirthMaintenanceMarylandMineralsOsteoporosisOutcomeParticipantPathway interactionsPatientsPatternPeer ReviewPublicationsPublishingQuality of lifeRare DiseasesReportingRequest for ApplicationsResearchResearch PersonnelScientistSkeletal systemSkeletonSocietiesSurgeonTexasTherapeuticTranslational ResearchUnderrepresented MinorityUnited StatesUnited States National Institutes of HealthUpdateWomanabstractingbonebone healthbone massdesigndisabilitydrug discoveryimprovedinsightlecturesmeetingsnovelpreventprogramspublic health relevanceskeletalsymposium
项目摘要
DESCRIPTION (provided by applicant): Bone health is critical to overall health and quality of life; the skeletal system provides the body mobility, support and protection, and serves as a major reservoir for essential minerals. But not everyone enjoys good bone health. To date, nearly 500 unique rare bone diseases have been described, which in the aggregate affect 1 in 5,000 live births, and comprise 5% of all birth defects. Typically the disability caused by these diseases affects individuals throughout their lives. Currently, the vast majority of these disorder have no cure, yet studying rare bone diseases has helped elucidate biological pathways and reveal valuable targets for drug discovery that are benefitting patients with common bone diseases too. This grant application requests partial support for "Mechanistic and Therapeutic Insights into Skeletal Biology Learned from the Study of Rare Bone Diseases," a workshop being coordinated by the National Bone Health Alliance (NBHA) in partnership with the Rare Bone Disease Patient Network and with the support of the American Society for Bone and Mineral Research (ASBMR) and the United States Bone and Joint Initiative (USBJI). The specific aims of the workshop are to: 1) Convene a multi-disciplinary group of experts including researchers, clinicians, and patients with rare bone diseases to advance our understanding of skeletal biology and encourage the development of novel therapies to improve outcomes for individuals with both common and rare bone diseases; 2) Identify gaps in our knowledge regarding the biologic mechanisms underlying rare bone disorders and share effective research strategies in translational and therapeutic areas; 3) Encourage broad participation both by holding the event the day before the ASBMR 2014 Annual Meeting and providing funding for a significant number of young investigators to attend; and 4) Disseminate the results broadly by publishing the proceedings of the program in a peer-reviewed journal. The one-day workshop will be held on September 11, 2014 in Houston, Texas, the day before the ASBMR 2014 Annual Meeting, the premier gathering of academic and clinical leaders in bone and mineral research. This pairing will encourage the greatest number of scientists, clinicians, and young investigators to participate in the workshop. The workshop will include lectures by invited speakers, and multiple opportunities to initiate collaborations and encourage future research partnerships. The planning committee has been confirmed and will ensure inclusion of women, individuals with disabilities, and participants from underrepresented groups.
描述(由申请人提供):骨骼健康对于整体健康和生活质量至关重要;骨骼系统提供身体的活动性、支撑和保护,并作为必需矿物质的主要储存库。但并不是每个人都享有良好的骨骼健康。迄今为止,已有近 500 种独特的罕见骨病被描述,这些疾病总共影响五千分之一的活产儿,占所有出生缺陷的 5%。通常,这些疾病引起的残疾会影响个人的一生。目前,绝大多数此类疾病无法治愈,但研究罕见骨病有助于阐明生物学途径,并揭示有价值的药物发现靶点,这些靶点也使常见骨病患者受益。本拨款申请要求部分支持“从罕见骨病研究中获得的骨骼生物学机制和治疗见解”,该研讨会由国家骨健康联盟 (NBHA) 与罕见骨病患者网络和罕见骨病患者网络合作协调举办。美国骨与矿物质研究学会 (ASBMR) 和美国骨与关节倡议 (USBJI) 的支持。研讨会的具体目标是: 1) 召集一个由研究人员、临床医生和罕见骨病患者组成的多学科专家组,以增进我们对骨骼生物学的理解,并鼓励开发新疗法,以改善罕见骨病患者的治疗结果常见和罕见的骨病; 2) 找出我们在罕见骨病生物学机制方面的知识差距,并分享转化和治疗领域的有效研究策略; 3) 通过在ASBMR 2014年会前一天举办活动并为大量年轻研究者参加提供资金来鼓励广泛参与; 4) 通过在同行评审期刊上发表该项目的会议记录来广泛传播结果。为期一天的研讨会将于 2014 年 9 月 11 日在德克萨斯州休斯顿举行,即 ASBMR 2014 年年会的前一天,这是骨和矿物研究领域学术和临床领导者的重要聚会。这种配对将鼓励尽可能多的科学家、临床医生和年轻研究人员参加研讨会。研讨会将包括受邀演讲者的讲座,以及发起合作和鼓励未来研究伙伴关系的多种机会。规划委员会已经确定,并将确保妇女、残疾人和代表性不足群体的参与者的参与。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mechanistic and therapeutic insights gained from studying rare skeletal diseases.
从研究罕见骨骼疾病中获得的机制和治疗见解。
- DOI:10.1016/j.bone.2015.03.016
- 发表时间:2015
- 期刊:
- 影响因子:4.1
- 作者:Tosi,LauraL;Warman,MatthewL
- 通讯作者:Warman,MatthewL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Matthew L Warman其他文献
Matthew L Warman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Matthew L Warman', 18)}}的其他基金
Conditional mouse models with dominant negative Osteogenesis Imperfecta
显性负性成骨不全的条件小鼠模型
- 批准号:
10646852 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Neurobehavioral phenotypes of mouse models of Osteogenesis Imperfecta
成骨不全小鼠模型的神经行为表型
- 批准号:
10416072 - 财政年份:2021
- 资助金额:
$ 2.5万 - 项目类别:
Neurobehavioral phenotypes of mouse models of Osteogenesis Imperfecta
成骨不全小鼠模型的神经行为表型
- 批准号:
10303525 - 财政年份:2021
- 资助金额:
$ 2.5万 - 项目类别:
The Efficacy of combination therapy in Osteogenesis Imperfecta
联合治疗成骨不全症的疗效
- 批准号:
8900679 - 财政年份:2015
- 资助金额:
$ 2.5万 - 项目类别:
Non-heritable genetic diseases of the skeletal system: Pathogenesis and Treatment
骨骼系统非遗传性遗传疾病:发病机制和治疗
- 批准号:
9052710 - 财政年份:2014
- 资助金额:
$ 2.5万 - 项目类别:
Non-heritable genetic diseases of the skeletal system: Pathogenesis and Treatment
骨骼系统非遗传性遗传疾病:发病机制和治疗
- 批准号:
8830919 - 财政年份:2014
- 资助金额:
$ 2.5万 - 项目类别:
Non-heritable genetic diseases of the skeletal system: Pathogenesis and Treatment
骨骼系统非遗传性遗传疾病:发病机制和治疗
- 批准号:
9245631 - 财政年份:2014
- 资助金额:
$ 2.5万 - 项目类别:
Does increasing bone mass also increase bone strength in mouse models of OI?
增加骨量是否也会增加成骨不全小鼠模型的骨强度?
- 批准号:
8232602 - 财政年份:2011
- 资助金额:
$ 2.5万 - 项目类别:
相似国自然基金
HTRA1介导CTRP5调控脂代谢通路在年龄相关性黄斑变性中的致病机制研究
- 批准号:82301231
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PLAAT3降低介导线粒体降解异常在年龄相关性白内障发病中的作用及机制
- 批准号:82301190
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
跨尺度年龄自适应儿童头部模型构建与弥漫性轴索损伤行为及表征研究
- 批准号:52375281
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
ALKBH5通过SHP-1调控视网膜色素上皮细胞铁死亡在年龄相关性黄斑变性中的作用机制研究
- 批准号:82301213
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
视网膜色素上皮细胞中NAD+水解酶SARM1调控自噬溶酶体途径参与年龄相关性黄斑变性的机制研究
- 批准号:82301214
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Illuminating neurodegenerative tauopathy from somatic genomic landscapes of single human brain cells
从单个人脑细胞的体细胞基因组景观中阐明神经退行性 tau 病
- 批准号:
10686570 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Unraveling the synaptic and circuit mechanisms underlying a plasticity-driving instructive signal
揭示可塑性驱动指导信号背后的突触和电路机制
- 批准号:
10686592 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Hospice exposure and utilization among older African Americans with ADRD and their decisional support persons
患有 ADRD 的老年非洲裔美国人及其决策支持人员的临终关怀暴露和利用
- 批准号:
10679558 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别: